دورية أكاديمية
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
العنوان: | A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. |
---|---|
المؤلفون: | Zhang D; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Pan Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Yang Z; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zeng H; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Wang X; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Chen J; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Wang J; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zhang Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zhou Z; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Chen M; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Hu D; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. |
المصدر: | Journal of clinical medicine [J Clin Med] 2022 Dec 31; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 31. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2012]- |
مستخلص: | Background: Liver cancer is one of the most common malignant tumors, and worldwide, its incidence ranks sixth, and its morality third. Post-hepatectomy liver failure (PHLF) is the leading cause of death in patients who have undergone liver resection. This retrospective study investigated the risk factors for PHLF by predicting and constructing an index to evaluate the risk. This was achieved by combining the lab tests with an indocyanine green (ICG) clearance test. Methods: The study analyzed 1081 hepatocellular carcinoma (HCC) patients who had received liver resection at Sun Yat-sen University Cancer Center between 2005 and 2020. The patients were divided into a PHLF group ( n = 113) and a non-PHLF group ( n = 968), according to the International Study Group of Liver Surgery (ISGLS) criteria. Receiver operating characteristics (ROC) curves were then used to estimate the optimal cut-off values. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors. Finally, a nomogram was constructed where the calibration plot, the areas under the ROC curve (AUC), and the decision curve analysis (DCA) showed good predictive ability. Results: Correlation analysis revealed that body mass index (BMI) was positively correlated with ICG-R15 and with effective hepatic blood flow (EHBF). Univariate and multivariate logistics regression analysis revealed that BMI, ICG-R15, international normalized ratio (INR), tumor size, hepatic inflow occlusion (HIO) time, and operation method were independent predictive factors for PHLF. When these factors and EHBF were included in the nomogram, the nomogram showed a good predictive value, with a C-index of 0.773 (95% Confidence Interval [CI]: 0.729-0.818). The INR had the largest ROC areas (AUC INR = 0.661). Among the variables, ICG-R15 (AUC ICG-R15 = 0.604) and EHBF (AUC EHBF = 0.609) also showed good predictive power. Conclusions: The risk of PHLF in HCC patients can be precisely predicted by this model prior to the operation. By integrating EHBF into the model, HCC patients at higher risk for PHLF can be identified more effectively. |
References: | JHEP Rep. 2020 Jun 04;2(4):100134. (PMID: 32695968) Liver Cancer. 2014 Oct;3(3-4):458-68. (PMID: 26280007) Major Probl Clin Surg. 1964;1:1-85. (PMID: 4950264) Acta Med Indones. 2019 Oct;51(4):356-363. (PMID: 32041922) Hepatology. 2000 Apr;31(4):864-71. (PMID: 10733541) Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):246-254. (PMID: 32282547) Hepatobiliary Surg Nutr. 2014 Oct;3(5):238-46. (PMID: 25392835) J Hepatol. 1993 Aug;19(1):4-7. (PMID: 8301041) Ann Surg. 2002 Nov;236(5):602-11. (PMID: 12409666) Hepatology. 2003 Aug;38(2):518-26. (PMID: 12883497) Lancet Oncol. 2008 Nov;9(11):1092-101. (PMID: 19012858) J Gastrointest Surg. 2021 Jul;25(7):1727-1735. (PMID: 32779082) Neuroimage Clin. 2015 Mar 24;8:1-31. (PMID: 26110109) BMC Gastroenterol. 2017 Dec 29;17(1):171. (PMID: 29284411) Gut. 2019 Dec;68(12):2195-2205. (PMID: 31358576) Clin Microbiol Rev. 2008 Jan;21(1):13-25. (PMID: 18202435) J Cancer. 2021 May 27;12(15):4455-4462. (PMID: 34149909) Gastroenterology. 1988 Sep;95(3):749-59. (PMID: 3396820) Liver Transpl. 2004 Feb;10(2 Suppl 1):S58-63. (PMID: 14762841) JAMA. 1967 Apr 17;200(3):236-40. (PMID: 6071462) Ann Surg. 2016 Aug;264(2):330-8. (PMID: 26587849) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) World J Surg. 2013 May;37(5):1028-33. (PMID: 23423450) Surgeon. 2022 Oct;20(5):e288-e295. (PMID: 35144899) J Hepatobiliary Pancreat Sci. 2021 Jan;28(1):86-94. (PMID: 33052632) Ann Surg. 2004 Oct;240(4):698-708; discussion 708-10. (PMID: 15383797) Liver Transpl. 2003 Sep;9(9):S18-25. (PMID: 12942474) Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9. (PMID: 16327492) J Clin Oncol. 2015 Feb 20;33(6):550-8. (PMID: 25512453) Liver Cancer. 2020 Dec;9(6):682-720. (PMID: 33442540) J Surg Oncol. 2018 Sep;118(3):440-445. (PMID: 30259515) Surg Clin North Am. 2004 Apr;84(2):355-73. (PMID: 15062650) Clin Mol Hepatol. 2019 Mar;25(1):1-11. (PMID: 30086613) Hepatology. 2017 Aug;66(2):675-676. (PMID: 28437858) Surgery. 2011 May;149(5):713-24. (PMID: 21236455) |
فهرسة مساهمة: | Keywords: ICG clearance test; ICG-R15; body mass index; effective hepatic blood flow; post-hepatectomy liver failure |
تواريخ الأحداث: | Date Created: 20230108 Latest Revision: 20230111 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC9821206 |
DOI: | 10.3390/jcm12010324 |
PMID: | 36615125 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2077-0383 |
---|---|
DOI: | 10.3390/jcm12010324 |